Micatu Joins the CCIC Family.

    Painted Post, NY, December 11, 2012—Micatu, Inc. provider of next generation optical based sensors, measurement and biomedical instruments, announced today the relocation of its business operations to the Ceramics Corridor Innovation Center (CCIC).  The new facility, located at 109 Canada Road, Painted Post, New York, 14870, will accommodate the company’s staff expansion to meet the company’s recent growth within the Oncology medical instrumentation markets. 

    “This presents a great opportunity to leverage the technical synergies between Micatu and the Ceramics Corridor Innovation Center (CCIC) in a cost effective manner,” stated Michael Oshetski, CEO of Micatu, Inc. “As Micatu grows, we have the access to flexible facilities for both corporate offices and specialized laboratory space. This gives us a differential advantage to meeting our customers’ needs by focusing on the bottom line, and freeing up operational capital for new opportunities.”

    “Our internal management team is comprised of a blended mix of senior technical, visionary and commercialization practice management to ensure that our advances in technology are matched with real world demand and that our research results in a commercialized product or service offering”, stated Mike Jagielski, Micatu’s Chief Operating Officer. 

    “Recently, Micatu was awarded an exclusive license from a prestigious US Government Federal Agency for the design, production and commercialization of a bio-medical instrument that has the capability of reducing existing technology costs for similar instruments by a factor of 25X to 50X.  Micatu was distinguished as the clear winner in a field of almost 50 entrants by demonstrating our commercialization ability first and foremost, followed by our advanced technical expertise.”        

    Micatu’s new facility is centrally located in Upstate New York, next to the I-86 corridor and the Elmira regional airport (ELM).

    About Micatu: Micatu innovates and pioneers advanced technologies that enable next generation optical based sensors, measurement and biomedical instruments. We drive first to market technologies that are highly accurate, highly precise, which enable our customers to achieve profitable and sustainable operations. Micatu’s inventive culture, combined with practicality, had enabled next generation instruments within our key product lines while reducing costs for our customers.  For more information, please see us on the web at: www.micatu.com.